Close Menu
    What's Hot

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026

    More UK Life Insurer Equity Release Securitisation on the Horizon?

    February 25, 2026

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    February 25, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

      February 25, 2026

      IBM I.T. Solutions Pension Scheme Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 19, 2026

      Sopra Steria Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With Standard Life for Management Plan Section

      February 19, 2026

      Avon Cosmetics Completes Bulk Purchase Annuity Buy-In With M&G

      February 19, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      More UK Life Insurer Equity Release Securitisation on the Horizon?

      February 25, 2026

      Q&A: Dr. Joshua Funder, CEO and Managing Director, Household Capital

      February 25, 2026

      Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains

      February 11, 2026

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

      February 25, 2026

      More UK Life Insurer Equity Release Securitisation on the Horizon?

      February 25, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Q&A: Dr. Joshua Funder, CEO and Managing Director, Household Capital

      February 25, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Encouraging Signs for Institutional Investors Looking at Reverse Mortgage Securitisations

    Secondary Life Markets February 12, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The trend in reverse mortgage origination in the US in the past decade or so has been down, down, down. According to the National Reverse Mortgage Lenders Association, fiscal year 2024 – which, for the Department of Housing and Urban Development (HUD), ended on 30th September last year – delivered just 26,521 HECM mortgages, the lowest number since 2003 (18,097). 

    The story in the securitisation market has not been quite so negative, however. Tail issuance and growing loan balances over time provide additional capital that can be securitised to maintain healthy activity in the market. Indeed, HMBS issuance data from Ginnie Mae shows that December saw $575m worth of activity, the third best month since 2023. 

    “Over time, the HMBS market has expanded, despite lackluster HECM origination volume,” said Michael McCully, Partner at New View Advisors, “with the notable exception to that trend during the pandemic.” 

    “Because of agency – and particularly Ginnie Mae – liquidity in the secondary markets, lower volume has not proven to affect the depth of the market, trading, or pricing in HMBS. Low volume was a fear in 2010 when FHA made its first (and most dramatic) PLF reductions, but it proved not to be true.” 

    Then, in November, the market received a very welcome shot in the arm, as Ginnie Mae announced the terms for ‘HMBS 2.0’, the agency’s attempt at providing additional liquidity to the market. 

    First mooted more than a year ago, HMBS 2.0 notably increases the mandatory buyout threshold to 150% of the maximum claim amount (MCA, up from 98%), which, in aggregate, will provide significantly more flexibility to HMBS issuers before mandatory buyouts are required.  

    The impact of this on the availability of HMBS products for investors could be significant. 

    “Based on the final HMBS 2.0 term sheet, up to $431m per month of buyouts would have been eligible for HMBS 2.0 in 2024. That almost doubles HMBS volume, which was $6bn last year,” said McCully. 

    Other benefits of this development accrue to the institutional investor. The repurchase of loans at the original 98% MCA threshold leads to an acceleration of prepayments within the HMBS pool, so investors receive their principal back sooner than anticipated, which can affect the expected yield of the security. Additionally, early loan buyouts can disrupt the anticipated cash flows to investors, potentially leading to reinvestment risk, and by repurchasing the loans, issuers assume the associated credit risks until the loans are either assigned to HUD or otherwise resolved. 

    So, an encouraging development for capital allocators. But 2024 did not only deliver good news from the US market. Last July, the Australian market saw its first securitisation of reverse mortgages in many years when non-bank lender Household Capital issued securitised product rated by Moody’s. Joshua Funder, CEO at Household Capital, says that this is just the beginning. 

    “We expect to return to the securitisation market annually for the foreseeable future with increasing volumes of high quality, rated Australian variable rate reverse mortgage portfolios,” he said.  

    An interesting difference between the US and Australian markets is that the latter does not enjoy the benefits of having a federal backstop, something which provides great comfort to those with exposure to the US HMBS market. 

    That doesn’t mean that the risk profile of Australian product is significantly lower, however.  

    The passing of the Consumer Credit Legislation Amendment (Enhancements) Bill in 2012 by the country’s lawmakers provided a swath of consumer protections which, for the country’s reverse mortgage market, meant Australia has among the lowest loan-to-value reverse mortgage ratios in the world. 

    In 2018, the market received an additional boost as the Australian Securities and Investment Commission’s review of the performance of these regulations found no material breach, but it is not only the regulatory environment that supports risk management in the space. 

    “Australian reverse mortgages are variable rate, and those variable rates are correlated with long-term property price appreciation. This provides additional risk reduction for negative equity, equity erosion and bequest reduction,” said Funder. 

    “Additionally, Australian equity release customers tend to discharge voluntarily around 12% per annum, making the average weighted life around 8-9 years and de-coupling discharge from mortality alone and break fees.” 

    It is not just Funder who appears bullish on the market; an article in the November 2024 issue of the Australian Securitisation Journal by Moody’s says that the firm “expects Australian reverse mortgage and other equity release securitisation issuance to grow over time”. 

    The news story of the past few years in the primary equity release/reverse mortgages market has indeed been falling numbers of origination, as higher interest rates made these products more expensive for the consumer. 

    But now, things are looking up. Stateside, the Federal Reserve cut the Federal Funds Rate by 100bps in total in 2024, which should, other things being equal, drive demand; activity is pacing to deliver an increase this year. In the UK, green shoots appeared in the fourth quarter of last year.  

    And they are certainly looking up for the securitisation market, at least, in theory. US President Donald Trump’s federal hiring freeze, along with a raft of potential retirements, could delay the implementation of HMBS 2.0. But when it is finally implemented, institutional investors will have a larger menu from which to choose. 

    “As I said, we could see a doubling of HMBS volume thanks to the changes made by Ginnie Mae,” said McCully. 

    “More securitisation issuance provides more options to more investors. That, coupled with the expected increase in activity in the primary market, means that the next few years could see activity in the securitisation market reach new highs.” 

    2025 - February Equity Release / Reverse Mortgages Longevity Risk Mortality Risk Volume 4 Issue 2 - February 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026By Mark McCord

    More UK Life Insurer Equity Release Securitisation on the Horizon?

    February 25, 2026By Greg Winterton

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    February 25, 2026By Jamie Tucker and Jack Rosen

    Q&A: Dr. Joshua Funder, CEO and Managing Director, Household Capital

    February 25, 2026By Greg Winterton
    Latest Issue

    Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains

    February 11, 2026

    US Plan Sponsors Are Turning to OCIOs for Buy-Out Readiness

    February 11, 2026

    Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

    February 11, 2026

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.